*This article is an automatic translation of the original article, provided here for your convenience. Read the original article. The Court of Justice of the European Communities has therefore finally decided to refer the matter to the Court of Justice of the European Communities. rule on the merits on the abusive nature of the prohibition imposed by the pharmaceutical company GlaxoSmithKline to its Greek wholesalers to practise parallel imports of certain medicines into other countries Member States, where reimbursement of the prices paid for medicinal products prescription drugs is significantly higher than that available on the market. practiced in Greece. She did so this morning, 16 September 2008, in the Cases C-468/06 to C-478/06 (Sot. Lélos Kai Sia E.E. and Others v
ALERTS : UNILATERAL PRACTICE - ABUSE OF DOMINANT POSITION - PHARMACEUTICAL PRODUCTS - REFUSAL TO SUPPLY - ORDINARY ORDERS
Parallel exports: The EU Court of Justice paves the way for the possibility to limit the quantity of drugs destined to wholesalers engaged in parallel exports when the ordered quantities are out of proportion to the quantities usually sold (GlaxoSmithKline)
Access to this article is restricted to subscribers
Already Subscribed? Sign-in
Access to this article is restricted to subscribers.
Read one article for free
Sign-up to read this article for free and discover our services.